Finding the right targets for CAR T-cell therapy in AML
Speaking from the 2018 European School of Hematology (ESH) Clinical Updates on Acute Leukemias, held in Budapest, Hungary, Arnold Ganser, MD, from the Hannover Medical School, Hannover, Germany, expla...
Author: VJHemOnc
Added: 05/29/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 29, 2018 Category: Cancer & Oncology Source Type: podcasts
Increasing the effectiveness of ALL therapies
Speaking from the 2018 European School of Hematology (ESH) Clinical Updates on Acute Leukemias, held in Budapest, Hungary, Charles Mullighan, MBBS (Hons), MSc, MD, from St. Jude Childrens Research Ho...
Author: VJOncology
Added: 05/18/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 18, 2018 Category: Cancer & Oncology Source Type: podcasts
Finding the right targets for CAR T-cell therapy in AML
Speaking from the 2018 European School of Hematology (ESH) Clinical Updates on Acute Leukemias, held in Budapest, Hungary, Arnold Ganser, MD, from the Hannover Medical School, Hannover, Germany, expla...
Author: VJOncology
Added: 05/17/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 17, 2018 Category: Cancer & Oncology Source Type: podcasts
Brain drain
How much does it cost sub-Saharan countries to train all the doctors who end up working in the UK, US, Canada, and Australia? Edward Mills from the University of Ottawa explains his economic analysis of healthcare migration. Also Hungarian health minister Mikl ós Szócska talks about his country's challenges and plans when it comes to improving... (Source: The BMJ Podcast)
Source: The BMJ Podcast - August 27, 2013 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
Brain drain
How much does it cost sub-Saharan countries to train all the doctors who end up working in the UK, US, Canada, and Australia? Edward Mills from the University of Ottawa explains his economic analysis of healthcare migration. Also Hungarian health minister Miklós Szócska talks about his country's challenges and plans when it comes to improving health outcomes, currently among the worst in Europe. (Source: The BMJ Podcast)
Source: The BMJ Podcast - August 27, 2013 Category: General Medicine Authors: BMJ Group Source Type: podcasts
ASFH Zoltan Nagy on easing into femtosecond cataract surgery and John Kanellopoulos on high fluence riboflavin crosslinking
Guests: Zoltan Z. Nagy, MD
Professor at the Department of Ophthalmology
Semmelweis University
Budapest, Hungary
John Kanellopoulos, MD
Professor of Ophthalmology
NYU School of Medicine
New York, NY
Director, Laservision.gr Institute
Athens, Greece (Source: As Seen From Here)
Source: As Seen From Here - July 4, 2013 Category: Opthalmology Authors: JYoungMD at gmail.com Source Type: podcasts
